Clinical Trials Browser

Withdrawn × INDUSTRY × Burkitt Lymphoma × Clear all

NCT07196111 2026-05-28

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Phase EARLY_PHASE1 Withdrawn

Burkitt Lymphoma, Lymphoma

NCT06009107 2025-08-08

B-ALL

Phase 1/2 Withdrawn

Burkitt Lymphoma

NCT04156659 2023-03-09

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Phase 2 Withdrawn

Burkitt Lymphoma

NCT02973191 2017-04-10

ORBIT

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02215629 2017-01-27

Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT00886496 2012-06-20

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Phase 1 Withdrawn

LymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fever, Infections, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neutropenia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Hot Flashes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating